908 Devices Analyst Price Targets - Benzinga

908 Devices Inc

MASSNASDAQ

Trade with Public

Trade with Public

$10.33

-0.32-3%

At close: Sep 2, 5:00 PM EST

$10.33

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

908 Devices Analyst Price Targets

Wall Street analyst price targets and consensus rating for 908 Devices (MASS).

Price Target Range — 6 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingOutperform# Analysts4Avg. Consensus PT$11Upside to Avg. PT+6.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 12, 2026	Stifel	Daniel Arias	PT Raise	Buy	$10→$12
Aug 12, 2026	Roth Capital	Max Masucci	PT Raise	Buy	$11→$13
Jul 29, 2026	Roth Capital	Max Masucci	Initiate	Buy	$11
Aug 5, 2025	Leerink Partners	Puneet Souda	Upgrade	Market Perform→Outperform	$12
Jan 15, 2025	Stephens & Co.	Jacob Johnson	Maintained	Overweight	$6
Nov 13, 2024	Leerink Partners	Puneet Souda	Downgrade	Outperform→Market Perform	$12→$4
Nov 13, 2024	Stifel	Daniel Arias	PT Cut	Buy	$17→$6
Oct 17, 2024	Leerink Partners	—	PT Cut	Outperform	$15→$12
May 13, 2024	Stephens & Co.	Jacob Johnson	Maintained	Overweight	$14
Sep 25, 2023	Stephens & Co.	Jacob Johnson	Maintained	Overweight	$14

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Stifel Maintains Buy on 908 Devices, Raises Price Target to $12

Stifel analyst Daniel Arias maintains 908 Devices (NASDAQ:MASS) with a Buy and raises the price target from $10 to $12.

Benzinga Newsdesk

PRO
Roth Capital Maintains Buy on 908 Devices, Raises Price Target to $13

Roth Capital analyst Max Masucci maintains 908 Devices (NASDAQ:MASS) with a Buy and raises the price target from $11 to $13.

Benzinga Newsdesk

This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. Analyst rating changes include upgrades, downgrades, and initiations. See page for details.

Avi Kapoor

PRO
Roth Capital Initiates Coverage On 908 Devices with Buy Rating, Announces Price Target of $11

Roth Capital analyst Max Masucci initiates coverage on 908 Devices (NASDAQ:MASS) with a Buy rating and announces Price Target of $11.

Benzinga Newsdesk

PRO
Leerink Partners Upgrades 908 Devices to Outperform, Announces $12 Price Target

Leerink Partners analyst Puneet Souda upgrades 908 Devices (NASDAQ:MASS) from Market Perform to Outperform and announces $12 price target.

Benzinga Newsdesk

908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth

Repligen acquires 908 Devices' desktop portfolio for $70 million, enhancing its bioprocessing analytics. 908 Devices shifts focus to handheld growth, forecasting revenue gains.

Vandana Singh